BALAXI PHARMACEUTICALS
|
BALAXI PHARMACEUTICALS Last 5 Year Cashflow Statement History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Profit Before Tax | ₹5.29 Cr | ₹29 Cr | ₹2.02 Cr | ₹57 Cr | ₹55 Cr |
| Adjustment | ₹22 Cr | ₹7.43 Cr | ₹-1.14 Cr | ₹8.03 Cr | ₹1.18 Cr |
| Changes In working Capital | ₹-27 Cr | ₹-68 Cr | ₹11 Cr | ₹-47 Cr | ₹-16 Cr |
| Cash Flow after changes in Working Capital | ₹0.22 Cr | ₹-32 Cr | ₹12 Cr | ₹18 Cr | ₹40 Cr |
| Cash Flow from Operating Activities | ₹-4.50 Cr | ₹-35 Cr | ₹4.87 Cr | ₹6.08 Cr | ₹34 Cr |
| Cash Flow from Investing Activities | ₹-21 Cr | ₹-22 Cr | ₹-1.05 Cr | ₹-11 Cr | ₹-28 Cr |
| Cash Flow from Financing Activities | ₹0.44 Cr | ₹34 Cr | ₹30 Cr | ₹26 Cr | ₹-0.16 Cr |
| Net Cash Inflow / Outflow | ₹-25 Cr | ₹-23 Cr | ₹34 Cr | ₹21 Cr | ₹5.53 Cr |
| Opening Cash & Cash Equivalents | ₹39 Cr | ₹62 Cr | ₹28 Cr | ₹7.19 Cr | ₹1.66 Cr |
| Cash & Cash Equivalent on Amalgamation / Take over / Merger | - | - | - | - | - |
| Cash & Cash Equivalent of Subsidiaries under liquidations | - | - | - | - | - |
| Translation adjustment on reserves / op cash balalces frgn subsidiaries | - | - | - | - | - |
| Effect of Foreign Exchange Fluctuations | - | - | - | - | - |
| Closing Cash & Cash Equivalent | ₹15 Cr | ₹39 Cr | ₹62 Cr | ₹28 Cr | ₹7.19 Cr |
Compare Cashflow Statement of peers of BALAXI PHARMACEUTICALS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| BALAXI PHARMACEUTICALS | ₹131.6 Cr | 8.6% | 7.4% | -45.8% | Stock Analytics | |
| ADANI ENTERPRISES | ₹370,378.0 Cr | 0% | 1.6% | 19% | Stock Analytics | |
| ADITYA INFOTECH | ₹51,654.2 Cr | 2% | -3.6% | 174.6% | Stock Analytics | |
| AEGIS LOGISTICS | ₹43,490.7 Cr | 8.6% | -11% | 61.4% | Stock Analytics | |
| PREMIER ENERGIES | ₹40,492.5 Cr | -0.2% | -0.9% | -14.3% | Stock Analytics | |
| REDINGTON | ₹28,034.4 Cr | 9.5% | -8.6% | 17.9% | Stock Analytics | |
BALAXI PHARMACEUTICALS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| BALAXI PHARMACEUTICALS | 8.6% |
7.4% |
-45.8% |
| SENSEX | 3.3% |
13.9% |
-1.7% |
You may also like the below Video Courses